TERSERA Trademark

Trademark Overview

On Monday, February 8, 2016, a trademark application was filed for TERSERA with the United States Patent and Trademark Office. The USPTO has given the TERSERA trademark a serial number of 86900298. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, February 6, 2025. This trademark is owned by Tersera Therapeutics LLC. The TERSERA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines; pharmaceutical research and development and related services, namely, pharmaceutical drug development services
tersera

General Information

Serial Number86900298
Word MarkTERSERA
Filing DateMonday, February 8, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, February 6, 2025
Registration Number5807179
Registration DateTuesday, July 16, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2016

Trademark Statements

Goods and ServicesDevelopment of pharmaceutical preparations and medicines; pharmaceutical research and development and related services, namely, pharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 11, 2016
Primary Code042
First Use Anywhere DateWednesday, April 17, 2019
First Use In Commerce DateWednesday, April 17, 2019

Trademark Owner History

Party NameTersera Therapeutics LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDeerfield, IL 60015
Party NameTersera Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLake Forest, IL 60045
Party NameTersera Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60654

Trademark Events

Event DateEvent Description
Tuesday, June 28, 2016PUBLISHED FOR OPPOSITION
Thursday, February 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 24, 2016ASSIGNED TO EXAMINER
Tuesday, May 24, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 17, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, June 28, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 28, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, November 11, 2016EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, December 27, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 16, 2017SOU TEAS EXTENSION RECEIVED
Friday, June 16, 2017SOU EXTENSION 1 FILED
Friday, June 16, 2017SOU EXTENSION 1 GRANTED
Tuesday, June 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 17, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 27, 2018SOU EXTENSION 4 GRANTED
Tuesday, October 17, 2017SOU EXTENSION 2 FILED
Tuesday, October 17, 2017SOU EXTENSION 2 GRANTED
Thursday, October 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 5, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, June 5, 2018SOU EXTENSION 3 FILED
Tuesday, June 5, 2018SOU EXTENSION 3 GRANTED
Thursday, June 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 27, 2018SOU TEAS EXTENSION RECEIVED
Thursday, December 27, 2018SOU EXTENSION 4 FILED
Saturday, December 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 21, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, May 21, 2019USE AMENDMENT FILED
Sunday, June 2, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 3, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 12, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 13, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 16, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 16, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 20, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, January 15, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 5, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 6, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 6, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

tersera development pharmaceutical services drug namely research preparations medicines related